Advertisement

Association of Tumor Necrosis Factor Alpha-Induced Protein 3 Interacting Protein 1 (TNIP1) Gene Polymorphism (rs7708392) with Lupus Nephritis in Egyptian Patients

  • Mohamed Moustafa Rizk
  • Eman Tayae Elsayed
  • Ahmed Fathi ElKeraie
  • Ireny Ramzy
Original Article

Abstract

Lupus nephritis (LN) is a major cause of morbidity and mortality in systemic lupus erythematosus (SLE). Previous studies suggest that mutant A20 binding inhibitor of NF-κB 1 (ABIN1) protein encoded by tumor necrosis factor alpha-induced protein 3 interacting protein 1 (TNIP1) gene is associated with LN via NF-κB dysregulation. The aim of the current study was to evaluate the association of TNIP1 gene SNP rs7708392 with SLE and LN in Egyptian patients. 5′ nuclease Allelic discrimination was used to evaluate the frequency of TNIP1 SNP rs7708392 in 53 patients with LN, 57 SLE patients without nephritis and 85 healthy controls. The genotyping analysis revealed that the CC genotype was more frequent in controls than SLE patients, while GC and GG genotypes were more common in SLE patients. Moreover, the GG genotype and the G allele were significantly more prevalent among LN patient than non-LN patients (P < 0.001). In LN patients, the most common genotype was GG (56.6%), while among the non-LN patients; the CG genotype was the most common (59.6%). Regression analysis demonstrated that SLE patients carrying only one G allele had a 3.4 folds increased risk for LN. Our results suggested that TNIP1 SNP (rs7708392) might be associated with the LN in Egyptian SLE patients. TNIP1 SNP (rs7708392) might be used to identify patients at risk of developing LN, which could help in early detection and treatment before progression to end-stage renal disease, improving patients’ outcome and quality of life.

Keywords

Lupus nephritis SLE TNIP1 SNP (rs7708392) ABIN1 protein 

Notes

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflicts of interest that are directly relevant to the content of this article.

Ethical Approval

This research was conducted on human participants. The study was approved by the Ethics Committee of Alexandria University, Egypt.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

References

  1. Adrianto I, Wang S, Wiley GB et al (2012) Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus. Arthritis Rheum 64:3695–3705CrossRefPubMedPubMedCentralGoogle Scholar
  2. Akbar N, Nanda S, Belch J et al (2015) An important role for A20-binding inhibitor of nuclear factor-kB-1 (ABIN1) in inflammation-mediated endothelial dysfunction: an in vivo study in ABIN1 (D485 N) mice. Arthritis Res Ther 17:22CrossRefPubMedPubMedCentralGoogle Scholar
  3. Alvira CM (2014) Nuclear factor-kappa-B signaling in lung development and disease: one pathway, numerous functions. Birth Defects Res Part A 100:202–216CrossRefGoogle Scholar
  4. Borchers AT, Leibushor N, Naguwa SM et al (2012) Lupus nephritis: a critical review. Autoimmun Rev 12:174–194CrossRefPubMedGoogle Scholar
  5. Bossini-Castillo L, Martin JE, Broen J et al (2013) Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study. Ann Rheum Dis 72:602–607CrossRefPubMedGoogle Scholar
  6. Bowes J, Orozco G, Flynn E et al (2011) Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis. Ann Rheum Dis 70:1641–1644CrossRefPubMedPubMedCentralGoogle Scholar
  7. Caster DJ, Korte EA, Nanda SK et al (2013) ABIN1 dysfunction as a genetic basis for lupus nephritis. J Am Soc Nephrol 24:1743–1754CrossRefPubMedPubMedCentralGoogle Scholar
  8. Cervera R, Khamashta MA, Font J et al (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period. A comparison of early and late manifestations in a cohort of 1000 patients. Medicine 82:299–308CrossRefPubMedGoogle Scholar
  9. Crispín JC, Liossis SN, Kis-Toth K et al (2010) Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol Med 16:47–57CrossRefPubMedPubMedCentralGoogle Scholar
  10. Dooley MA, Aranow C, Ginzler EM (2004) Review of ACR renal criteria in systemic lupus erythematosus. Lupus 13(11):857–860CrossRefPubMedGoogle Scholar
  11. Faurschou M, Starklint H, Halberg P et al (2006) Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure. J Rheumatol 33:1563–1569PubMedGoogle Scholar
  12. Gateva V, Sandling JK, Hom G et al (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 41:1228–1233CrossRefPubMedPubMedCentralGoogle Scholar
  13. Harley IT, Kaufman KM, Langefeld CD et al (2009) Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies. Nat Rev Genet 10:285–290CrossRefPubMedPubMedCentralGoogle Scholar
  14. Hayden MS, Ghosh S (2004) Signaling to NF-κB. Genes Dev 18:2195–2224CrossRefPubMedGoogle Scholar
  15. Hayden MS, Ghosh S (2011) NF-κB in immunobiology. Cell Res 21:223–244CrossRefPubMedPubMedCentralGoogle Scholar
  16. He CF, Liu YS, Cheng YL et al (2010) TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chi- nese Han population. Lupus 19:1181–1186CrossRefPubMedGoogle Scholar
  17. Kalergis AM, Iruretagoyena MI, Barrientos MJ et al (2009) Modulation of nuclear factor-kappaB activity can influence the susceptibility to systemic lupus erythematosus. Immunology 128(Suppl):e306–e314CrossRefPubMedPubMedCentralGoogle Scholar
  18. Kawasaki A, Ito S, Furukawa H et al (2010) Association of TNFAIP3 interacting protein 1, TNIP1 with systemic lupus erythematosus in a Japanese population: a case-control association study. Arthritis Res Ther 12:R174CrossRefPubMedPubMedCentralGoogle Scholar
  19. Korte E, Caster D, Barati M (2017) ABIN1 determines severity of glomerulonephritis via activation of intrinsic glomerular inflammation. Am J Pathol 187:2799–2810CrossRefPubMedGoogle Scholar
  20. Lessard CJ, Ice JA, Adrianto I et al (2012) The genomics of autoimmune disease in the era of genome- wide association studies and beyond. Autoimmun Rev 11:267–275CrossRefPubMedGoogle Scholar
  21. Mauro C, Pacifico F, Lavorgna A et al (2006) ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB. J Biol Chem 281:18482–18488CrossRefPubMedGoogle Scholar
  22. Moser KL, Kelly JA, Lessard CJ et al (2009) Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun 10:373–379CrossRefPubMedPubMedCentralGoogle Scholar
  23. Nair RP, Duffin KC, Helms C et al (2009) Genome-wide scan reveals association of psoriasis with IL- 23 and NF-kB pathways. Nat Genet 41:199–204CrossRefPubMedPubMedCentralGoogle Scholar
  24. Nanda SK, Venigalla RK, Ordureau A et al (2011) Polyubiquitin binding to ABIN1 is required to prevent autoimmunity. J Exp Med 208:1215–1228CrossRefPubMedPubMedCentralGoogle Scholar
  25. Nanda SK, Lopez-Pelaez M, Arthur JS et al (2016) Suppression of IRAK1 or IRAK4 catalytic activity, but not type1 IFN signaling, prevents lupus nephritis in mice expressing a ubiquitin binding-defective mutant of ABIN1. J Immunol 197:4266–4273CrossRefPubMedPubMedCentralGoogle Scholar
  26. Oeckinghaus A, Ghosh S (2009) The NF-κB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 1:a000034CrossRefPubMedPubMedCentralGoogle Scholar
  27. Petri M, Orbai AM, Alarcon GS et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686CrossRefPubMedPubMedCentralGoogle Scholar
  28. Ramos PS, Brown EE, Kimberly RP et al (2010) Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis. Semin Nephrol 30:164–176CrossRefPubMedPubMedCentralGoogle Scholar
  29. Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277CrossRefPubMedGoogle Scholar
  30. Tazi J, Bakkour N, Stamm S (2009) Alternative splicing and disease. Mol Basis Dis 1792:14–26CrossRefGoogle Scholar
  31. Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365:2110–2121CrossRefPubMedGoogle Scholar
  32. Turnpnny P, Ellard S (2007) Emery’s elements of medical genetics. Elsevier/Churchill Livingstone, PhiladelphiaGoogle Scholar
  33. Vereecke L, Beyaert R, van Loo G (2009) The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol 30:383–391CrossRefPubMedGoogle Scholar
  34. Weening JJ, D’Agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241–250CrossRefPubMedGoogle Scholar
  35. Zhang H, Sun SC (2015) NF-κB in inflammation and renal diseases. Cell Biosci 5:63CrossRefPubMedPubMedCentralGoogle Scholar
  36. Zhang J, Chen Y, Shao Y et al (2012) Identification of TNIP1 polymorphisms by high resolution melting analysis with unlabelled probe: association with systemic lupus erythematosus. Autoimmune Dis 2012:265823PubMedPubMedCentralGoogle Scholar
  37. Zheng L, Sinniah R, Hsu SI (2006) In situ glomerular expression of activated NF-kappaB in human lupus nephritis and other non-proliferative proteinuric glomerulopathy. Virchows Arch 448:172–183CrossRefPubMedGoogle Scholar
  38. Zheng L, Sinniah R, Hsu SI (2008) Pathogenic role of NF-kappaB activation in tubulointerstitial inflammatory lesions in human lupus nephritis. J Histochem Cytochem 56:517–529CrossRefPubMedPubMedCentralGoogle Scholar
  39. Zhong H, Li XL, Li M et al (2011) Replicated associations of TNFAIP3, TNIP1 and ETS1 with systemic lupus erythematosus in a southwestern Chinese population. Arthritis Res Ther 13:R186CrossRefPubMedPubMedCentralGoogle Scholar
  40. Zubair A, Frieri M (2013) NF-κB and systemic lupus erythematosus: examining the link. J Nephrol 26:953–959CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Clinical Pathology Department, Faculty of MedicineAlexandria UniversityAlexandriaEgypt
  2. 2.Internal Medicine Department – Nephrology unit, Faculty of MedicineAlexandria UniversityAlexandriaEgypt

Personalised recommendations